Nelarabine Injection
Product Images NDC 70710-1839

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nelarabine (NDC 70710-1839). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (A24668ff F86f 470b A65b Baf0ce5b4a70 01)

Chemical structure of Nelarabine shown in a two-dimensional molecular diagram. The structure highlights the arrangement of atoms and bonds characteristic of Nelarabine's chemical composition.*

FDA Label Image

Container (A24668ff F86f 470b A65b Baf0ce5b4a70 02)

Nelarabine Injection 5 mg/mL in a 50 mL single-dose vial label. The label states the total strength as 250 mg per 50 mL, intended for intravenous infusion. It includes usage instructions, storage conditions, and manufacturer information for Cadila Healthcare Ltd., distributed by Zydus Pharmaceuticals USA Inc.*

FDA Label Image

Carton Of 1s (A24668ff F86f 470b A65b Baf0ce5b4a70 03)

Packaging label for Nelarabine Injection 5 mg/mL, 250 mg/50 mL in a 50 mL single-dose vial. The label shows that the product is for intravenous infusion only and is distributed by Zydus Pharmaceuticals USA Inc. It includes storage instructions and notes the product is manufactured by Cadila Healthcare Ltd., India. The label also displays the product NDC 70710-1839-1 and warnings about vial stopper material and solution quality.*

FDA Label Image

Carton Of 6s (A24668ff F86f 470b A65b Baf0ce5b4a70 04)

Packaging label for Nelarabine Injection 250 mg/50 mL (5 mg/mL) intravenous injection. The carton contains 6 single-dose vials of 50 mL each. Labeler is Zydus Pharmaceuticals USA Inc. The product is marked for intravenous infusion only with instructions to discard unused portions. The label also shows manufacturing by Cadila Healthcare Ltd., India, and distribution by Zydus Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.